Wire Stories
-
26.3KEntravision Announced as the Authorized Sales Partner of Meta in Mongolia
SANTA MONICA, Calif.–(BUSINESS WIRE)–Entravision (NYSE: EVC), a leading global advertising solutions, media and technology company, announced today that its Asia-based digital business...
-
27.8KEntravision Announced as the Authorized Sales Partner of Meta in Mongolia
SANTA MONICA, Calif.–(BUSINESS WIRE)–Entravision (NYSE: EVC), a leading global advertising solutions, media and technology company, announced today that its Asia-based digital business...
-
25.5KKuvare Expands Internationally with Three New Reinsurance Transactions; Closed Transaction Count Now Stands At Ten
HAMILTON, Bermuda–(BUSINESS WIRE)–Kuvare Holdings (�Kuvare�) is pleased to announce the closing of three additional strategic reinsurance transactions over the past two quarters....
-
27.3KHUAWEI XMAGE Trend Report 2023 Unveiled at Mobile World Congress
Exploring the Way Forward for Mobile Imagery BARCELONA, Spain–(BUSINESS WIRE)–Huawei has unveiled the HUAWEI XMAGE Trend Report 2023 during Mobile World Congress...
-
26.1KCity of Brawley, CA Selects PortalGuard� Identity and Access Management Cloud Platform for Enhanced Web Application and Workstation Security
BRAWLEY, Calif. and WALL, N.J., Feb. 27, 2023 (GLOBE NEWSWIRE) — BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and...
-
24.0KGilat Announces Availability of SkyEdge IV Taurus-M,�New Satellite Modem for Military and Government Markets
SkyEdge IV Taurus-M is backward compatible to SkyEdge II-c, providing investment protection and answering market demands for the smallest high-performance, rugged modem...
-
23.8KWP Engine�s Fourth Annual DE{CODE} Conference Doubles Registrations Fueling Interest in Open Source Innovation
The future of headless, advances in eCommerce, and the next generation of builder tools will take center stage at this year�s global...
-
68.8KElpiscience Announces First Patient Dosed for Phase 1 Clinical Trial of First-in-Class Anti-CD39xTGF-? Bispecific Antibody ES014
SHANGHAI & SUZHOU, China & GERMANTOWN, Md.–(BUSINESS WIRE)–Elpiscience Biopharmaceuticals, Inc. (�Elpiscience�), a clinical-stage biopharmaceutical company dedicated to developing life-changing immuno-oncology therapies for...
-
25.9KHCLTech launches suite of technology solutions for 5G and beyond
NOIDA, India & BARCELONA, Spain–(BUSINESS WIRE)–#5G–HCLTech, a leading global technology company, launched a range of innovative technology solutions for the 5G ecosystem...
-
27.4KBeiGene Reports Fourth Quarter and Full Year 2022 Financial Results
Recorded product revenue of $339.0 million and $1.3 billion for the fourth quarter and full year, respectively, increasing 72.3% and 97.9% from...
To Top